Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbamazepine vs Oxcarbazepine in Trigeminal Neuralgia
NCT07252453Active, not recruiting
- Sponsor
- Abbasi Shaheed Hospital
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of oxcarbazepine in trigeminal neuralgia (TN) (2 arms), sponsored by Abbasi Shaheed Hospital. Primary endpoint: Pain relief for TGN at 2 months. Started May 2025; status: active, not recruiting.
02
Drugs
oxcarbazepine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT07252453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252453.